Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
This map shows the geographic impact of Haruhiko Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Yagi more than expected).
This network shows the impact of papers produced by Haruhiko Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Yagi. The network helps show where Haruhiko Yagi may publish in the future.
Co-authorship network of co-authors of Haruhiko Yagi
This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Yagi.
A scholar is included among the top collaborators of Haruhiko Yagi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Haruhiko Yagi. Haruhiko Yagi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Hamanishi, Junzo, Masaki Mandai, Masashi Iwasaki, et al.. (2007). Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer. Proceedings of the National Academy of Sciences. 104(9). 3360–3365.1155 indexed citations breakdown →
Hecht, Stephen S., Menglan Chen, Haruhiko Yagi, Donald M. Jerina, & Steven G. Carmella. (2003). r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation.. PubMed. 12(12). 1501–8.60 indexed citations
4.
Hecht, Stephen S., Menglan Chen, Haruhiko Yagi, Donald M. Jerina, & Steven G. Carmella. (2003). r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in Human Urine. Cancer Epidemiology and Prevention Biomarkers. 12(12). 1501–1508.1 indexed citations
Slaga, Thomas J., William M. Bracken, Wayne Levin, et al.. (1978). Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(3). 678–81.37 indexed citations
11.
Kapitulnik, Jaime, Peter G. Wislocki, Wayne Levin, et al.. (1978). Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2). 354–8.210 indexed citations
12.
Levin, Wayne, Alexander W. Wood, Richard L. Chang, et al.. (1978). Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(6). 1831–4.42 indexed citations
13.
Wood, Alexander W., Wayne Levin, Paul E. Thomas, et al.. (1978). Metabolic activation of dibenzo(a,h)anthracene and its dihydrodiols to bacterial mutagens.. PubMed. 38(7). 1967–73.52 indexed citations
14.
Levin, Wayne, Alexander W. Wood, Peter G. Wislocki, et al.. (1977). Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 3356–61.60 indexed citations
15.
Wislocki, Peter G., Richard L. Chang, Alexander W. Wood, et al.. (1977). High carcinogenicity of 2-hydroxybenzo(a)pyrene on mouse skin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(8 Pt 1). 2608–11.43 indexed citations
16.
Slaga, Thomas J., William M. Bracken, Aurora Viaje, et al.. (1977). Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(11). 4130–3.70 indexed citations
17.
Levin, Wayne, Alexander W. Wood, Richard L. Chang, et al.. (1977). Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(8 Pt 1). 2721–5.79 indexed citations
Levin, Wayne, et al.. (1976). Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(9 pt.1). 3350–7.138 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.